Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02077881
Title Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NewLink Genetics Corporation
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Palo Alto California 94304 United States Details
Augusta University Augusta Georgia 30912 United States Details
University of Kentucy Lexington Kentucky 40536 United States Details
Washington University in St. Louis Saint Louis Missouri 63110 United States Details
The Vally Hospital Paramus New Jersey 07652 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
Greenville Health Systems Greenville South Carolina 29605 United States Details
Gibbs Cancer Center and Research Institute Spartanburg South Carolina 29303 United States Details
The West Clinic Memphis Tennessee 38120 United States Details
Huntsman Cancer Center Salt Lake City Utah 84112 United States Details
University of Vermont Medical Center Burlington Vermont 05401 United States Details
*Shaded cells indicate that there was no data available from for the field